Quince Therapeutics, Inc. enterprise value

The Enterprise Value as of October 2026 (TTM) for Quince Therapeutics, Inc. (QNCX) is -83770710.00

According to Quince Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -83770710.00. This represents a change of -227.48% compared to the average of 65.71M of the last 4 quarters.

Quince Therapeutics, Inc. (QNCX) Historical Enterprise Value (quarterly & annually)

How has QNCX Enterprise Value performed in the past?

The mean historical Enterprise Value of Quince Therapeutics, Inc. over the last ten years is 415.53M. The current -83770710.00 Enterprise Value has changed -120.16% with respect to the historical average. Over the past ten years (40 quarters), QNCX's Enterprise Value was at its highest in in the September 2021 quarter at 2.67B. The Enterprise Value was at its lowest in in the December 2022 quarter at -21107113.20.

Quince Therapeutics, Inc. (QNCX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Quince Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Quince Therapeutics, Inc. (QNCX) Average Enterprise Value

How has QNCX Enterprise Value performed in the past?

The current Enterprise Value of Quince Therapeutics, Inc. (QNCX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Quince Therapeutics, Inc. (QNCX) Enterprise Value vs. Peers

How is QNCX’s Enterprise Value compared to its peers?

Quince Therapeutics, Inc.’s Enterprise Value is less than aTyr Pharma, Inc. (10.29M), less than Precision BioSciences, Inc. (144.09M), less than InflaRx N.V. (113.27M), less than Metagenomi, Inc. Common Stock (28.54M), less than Fractyl Health, Inc. (26.50M), less than ALX Oncology Holdings Inc. (175.07M), less than Connect Biopharma Holdings Limited (22.73M), less than Adverum Biotechnologies, Inc. (159.14M), less than CAMP4 Therapeutics Corporation (149.94M), less than Kalaris Therapeutics Inc (2.34M),

Build a custom stock screener for Quince Therapeutics, Inc. (QNCX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quince Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Quince Therapeutics, Inc. (QNCX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Quince Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.